WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: 187_allergic rhinitis, Assess in 2-4 weeks Symptoms controlled?, Exclusions for self treatment? No Recommend measures to control exposure to allergens. Select drug therapy based on symptoms, Oral AH Congestion, INCS (preferred) or oral AH Assess in 2-4 weeks., INCS or oral AH Congestion, Sneezing, rhinorrhea, or itching Mild IAR symptoms, Moderate-severe IAR INCS or oral AH, Symptoms controlled? No Assess adherence. If adherent, increase dose or switch to alternative drug. If nonadherent, educate patient and continue therapy. Reassess in 1-2 weeks. If symptoms worsen or do not improve, refer patient for Rx therapy., Sneezing, rhinorrhea, or itching Moderate-severe PER, Recommend measures to control exposure to allergens. Select drug therapy based on symptoms Conjunctivitis, Congestion Yes Add oral or topical decongestant., Sneezing, rhinorrhea, or itching Moderate-severe IAR, Sneezing, rhinorrhea, or itching Mild PER, Assess in 2-4 weeks. Symptoms controlled?, Mild PER INCS or oral AH, Mild IAR symptoms Oral AH, Conjunctivitis Oral AH, intraocular AH, or saline., Recommend measures to control exposure to allergens. Select drug therapy based on symptoms Sneezing, rhinorrhea, or itching, Symptoms controlled? Yes Reduce dose and continue for 1 month., Exclusions for self treatment? Yes Medical Referral